Skip to main content

Clinical characteristics and prognostic factors of male yolk sac tumor: a Surveillance, Epidemiology, and End Results program study

Abstract

Introduction

Yolk sac tumor (YST) is a rare malignant germ cell tumor, which usually affects young males. Because of the low incidence, few studies on YST have been published. In our study, we aim to investigate the clinical characteristics, survival and risk factors of male YST patients based on the Surveillance, Epidemiology, and End Results (SEER) program.

Methods

We identified 569 male YST patients from the SEER-18 database with additional treatment fields. Clinical characteristics, survival and prognostic factors were described in the study. Chi-square tests were applied to analyze categorical and continuous variables between different groups. Univariate and multivariate Cox proportional hazard model were performed to assess the relative impacts of risk factors on cancer-specific survival (CSS) in YST patients. Kaplan–Meier method and the log-rank test were used to analyze differences in survival that were significant.

Results

The major primary sites of YST were testis (74.69%), mediastinum (15.47%), retroperitoneum (2.64%) and central nervous system (1.24%). The 3-year and 5-year CSS was 70.0%, 56.5% vs. 97.2%, 96.0% for the mediastinal and testicular YST patients, respectively (p < 0.001). Primary site of mediastinum, distant SEER Summary stage were independent factors of poor prognosis (hazard ratio (HR) = 2.010 (1.094–3.695), p = 0.025; HR = 6.501 (2.294–18.424), p < 0.001, respectively). Receiving surgery was a good prognosis factor for all patients (HR = 0.495 (0.260–0.940), p = 0.032) and for the mediastinal group (p = 0.0019). Being treated with chemotherapy indicated poor outcome in all patients (HR = 3.624 (1.050–12.507), p = 0.042) and in the localized testicular YST patients (p = 0.0077).

Conclusion

For the first time, our study revealed the primary site distribution of male YST, and summarized the clinical characteristics, survival and prognostic factors based on the SEER database, which provided important epidemiological evidence for clinical practice.

This is a preview of subscription content, access via your institution.

Fig. 1
Fig. 2
Fig. 3

References

  1. Teilum G (1959) Endodermal sinus tumors of the ovary and testis. Comparative morphogenesis of the so-called mesoephroma ovarii (Schiller) and extraembryonic (yolk sac-allantoic) structures of the rat’s placenta. Cancer 12:1092–1105

    CAS  Article  Google Scholar 

  2. Talerman A, Haije WG, Baggerman L (1980) Serum alphafetoprotein (AFP) in patients with germ cell tumors of the gonads and extragonadal sites: correlation between endodermal sinus (yolk sac) tumor and raised serum AFP. Cancer 46(2):380–385

    CAS  Article  Google Scholar 

  3. Talerman A (1980) Endodermal sinus (yolk sac) tumor elements in testicular germ-cell tumors in adults: comparison of prospective and retrospective studies. Cancer 46(5):1213–1217

    CAS  Article  Google Scholar 

  4. Hartmann JT, Einhorn L, Nichols CR et al (2001) Second-line chemotherapy in patients with relapsed extragonadal nonseminomatous germ cell tumors: results of an international multicenter analysis. J Clin Oncol 19(6):1641–1648

    CAS  Article  Google Scholar 

  5. Saxman S, Nichols CR, Williams SD, Loehrer PJ, Einhorn LH (1991) Mediastinal yolk sac tumor. The Indiana University experience, 1976 to 1988. J Thorac Cardiovasc Surg 102(6):913–916

    CAS  Article  Google Scholar 

  6. Guo YL, Zhang YL, Zhu JQ (2014) Primary yolk sac tumor of the retroperitoneum: a case report and review of the literature. Oncol Lett 8(2):556–560

    Article  Google Scholar 

  7. Uda H, Uda T, Nakajo K et al (2019) Adult-onset mixed germ cell tumor composed mainly of yolk sac tumor around the pineal gland: a case report and review of the literature. World Neurosurg 132:87–92

    Article  Google Scholar 

  8. Qureshi A, Al-Moundhri M, Al-Shaibi M, Al-Haddabi I, Mittal A (2018) Primary gastric yolk sac tumour. Sultan Qaboos Univ Med J 18(3):e383–e385

    Article  Google Scholar 

  9. Vanidassane I, Sharma V, Ramteke P, Yadav MK, Batra A (2019) Primary yolk sac tumor of the liver in an adult man. ACG Case Rep J 6(4):e00050

    Article  Google Scholar 

  10. Furr JR, Mellis AM, Slobodov G (2015) Primary yolk sac tumor of the prostate: a case report and review of the literature. Urol Int 95(2):240–242

    Article  Google Scholar 

  11. SEER Summary Stage Coding Instructions 2018, https://seer.cancer.gov/tools/ssm/

  12. Cornejo KM, Frazier L, Lee RS, Kozakewich HP, Young RH (2015) Yolk sac tumor of the testis in infants and children: a clinicopathologic analysis of 33 cases. Am J Surg Pathol 39(8):1121–1131

    Article  Google Scholar 

  13. Albers P, Albrecht W, Algaba F et al (2015) Guidelines on testicular cancer: 2015 update. Eur Urol 68(6):1054–1068

    Article  Google Scholar 

  14. Akasbi Y, Najib R, Arifi S et al (2014) Complete histologic response to chemotherapy in a patient with a mediastinal yolk sac tumor: a case report. BMC Res Notes 7:803

    Article  Google Scholar 

  15. Chaudhry IU, Rahhal M, Khurshid I, Mutairi H (2014) Radical surgical resection for giant primary mediastinal endodermal sinus tumour with pulmonary metastasis after chemotherapy: can be curative. BMJ Case Rep 2014:bcr20142046

    Google Scholar 

  16. Liu B, Lin G, Liu J, Liu H, Shang X, Li J (2018) Primary mediastinal yolk sac tumor treated with platinum-based chemotherapy and extended resection: report of seven cases. Thorac Cancer 9(4):491–494

    Article  Google Scholar 

  17. Sakaguchi M, Maebayashi T, Aizawa T, Ishibashi N, Fukushima S, Saito T (2016) Successful radiotherapy in postoperative recurrence of a primary mediastinal yolk sac tumor: a case report. Thorac Cancer 7(3):358–362

    Article  Google Scholar 

  18. Kesler KA, Rieger KM, Hammoud ZT et al (2008) A 25-year single institution experience with surgery for primary mediastinal nonseminomatous germ cell tumors. Ann Thorac Surg 85(2):371–378

    Article  Google Scholar 

Download references

Funding

None.

Author information

Affiliations

Authors

Contributions

Ruixuan Geng and Zhibo Zheng: protocol/project development, data collection or management, data analysis, manuscript writing/editing. Yuxiao Lin: manuscript writing/editing, Yaguang Li, Guannan Ge, Xiaoyan Dai, Qiuyue Ye, Junfeng Zhen: data collection or management. Jieshi Zhang: protocol/project development. Chenyu Wang: data analysis. Ying Zhang: data analysis. Chenwei Fu, Yongning Li: manuscript writing/editing.

Corresponding authors

Correspondence to Chenwei Fu or Yongning Li.

Ethics declarations

Ethics approval

1. The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in this manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties. 2. Since all information from the SEER database has been deidentified and no personal identifying information was used in our analysis, informed consent was not required in our study.

Conflict of interest

The authors of this article have no conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Geng, R., Zheng, Z., Lin, Y. et al. Clinical characteristics and prognostic factors of male yolk sac tumor: a Surveillance, Epidemiology, and End Results program study. World J Urol 39, 1211–1217 (2021). https://doi.org/10.1007/s00345-020-03311-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00345-020-03311-y

Keywords

  • Yolk sac tumor
  • Testis
  • Mediastinum
  • Prognosis
  • SEER